摘要
对硫唑嘌呤治疗视神经脊髓炎谱系病(NMOSD)致1例粒细胞缺乏进行分析,从硫唑嘌呤致造血系统损害的临床特点、发生率、不良反应预防、基因多态性以及NMOSD患者粒细胞缺乏的治疗措施等方面进行分析和讨论,为临床有效、安全用药提供参考。
One case of agranulocytosis induced by taking azathioprine for neuromyelitis optica spectrum disorders （NMOSD） was reported. And it was analyzed retrospectively in terms of clinical characteristics, incidence rate, precautionary measures of the adverse reactions, gene polymorphism and treatment of agranulocytosis for NMOSD patients, which may provide reference for effective and safe use of drugs in clinic.
出处
《药学与临床研究》
2017年第4期363-365,共3页
Pharmaceutical and Clinical Research
关键词
硫唑嘌呤
视神经脊髓炎谱系病
造血系统损害
重组人粒细胞集落刺激因子
Azathioprine
Neuromyelitis optica spectrum disorders
Hcmatopoietic system damage
Granulocyte colony stimulating factor
